| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.29 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |